Viewing Study NCT03783546



Ignite Creation Date: 2024-05-06 @ 12:32 PM
Last Modification Date: 2024-10-26 @ 1:00 PM
Study NCT ID: NCT03783546
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-19
First Post: 2018-12-19

Brief Title: Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer a Randomized Controlled Trial
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Study Overview

Official Title: Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer a Randomized Controlled Trial
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This research study is evaluating acupuncture a medical therapy in which hair-thin stainless steel needles are shallowly inserted into specific points to help the bodys natural healing process as a possible treatment to reduce hot flashes
Detailed Description: Hot flashes are a sensation of sudden onset of body warmth flushing and sweating Hot flashes are common side effects of breast cancer treatments and can affect mood and daily life Medications can help ease hot flashes but many patients continue to experience symptoms despite these treatments

Acupuncture is a complementary therapy in which hair-thin sterile disposable needles are inserted into various spots on the skin with the goal of affecting bodys natural healing system Acupuncture has been tested in clinical trials in cancer patients and has been shown to be helpful in treating a number of side effects of cancer treatment such as nausea and vomiting from chemotherapy A few early studies have suggested that acupuncture may help to lessen hot flashes but more information is needed about the benefits of acupuncture in breast cancer patients

This study is being done to test whether acupuncture can help to reduce the number and intensity of hot flashes in breast cancer patients who are being treated with mediations such as tamoxifen and aromatase inhibitors such as anastrozole Arimidex exemestane Aromasin and letrozole Femara

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None